Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 261-699-8 | CAS number: 59323-76-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Eye irritation
Administrative data
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 24-09-2014 to 26-09-2014
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Well reported study performed under GLP; using a commercially available human corneal epithelium model to manufacturer guideline with no significant deviations. Guideline currently under validation by the ECVAM.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 014
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- other: MatTek Corporation EpiOcular™ Eye Irritation Test (OCL-200-EIT)
- Deviations:
- yes
- Remarks:
- Tissue viability in meeting the acceptance criterion: the mean OD of three tissues is used at OD >= 1.0 instead of mean of two tissues according to guideline; no significant effect on the reliability of the study
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- inspected: July 2012; signature: April 2013
Test material
- Reference substance name:
- cis-2-methyl-4-propyl-1,3-oxathiane
- EC Number:
- 261-699-8
- EC Name:
- cis-2-methyl-4-propyl-1,3-oxathiane
- Cas Number:
- 59323-76-1
- Molecular formula:
- C8H16OS
- IUPAC Name:
- 2-methyl-4-propyl-1,3-oxathiane
- Test material form:
- gas under pressure: refrigerated liquefied gas
- Details on test material:
- - Physical state: liquid
- Storage condition of test material: In the refrigerator at 2 - 8 °C
- Other: colourless
Constituent 1
Test animals / tissue source
- Species:
- other: human-derived epidermal keratinocyte tissues
- Strain:
- not specified
Test system
- Vehicle:
- unchanged (no vehicle)
- Controls:
- other: Three tissues were used for the positive and negative control groups.
- Amount / concentration applied:
- TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 50 uL
- Concentration (if solution): undiluted - Duration of treatment / exposure:
- 30 minutes
- Number of animals or in vitro replicates:
- Three tissues were used for each treatment group (test item, negative control and positive control)
- Details on study design:
- - Details of the test procedure used: EpiOcular™ tissues were shipped at 2- 8 °C on medium-supplemented agarose gels in a 24-well plate. On day of receipt, EpiOcular™ tissues were kept in the refrigerator. After 24 hours and at least 1 hour prior to start of the assay, tissues were transferred to 6-well plates with 1 mL assay medium, pre-incubated, and transferred again to 6-well plates with assay medium. Prewarming: All incubations were done in the incubator at 37 ± 1.5 °C, 5 ± 0.5% CO2. Treatment: 37 ± 1.5 °C, 5 ± 0.5% CO2. MTT Assay: 37 ± 1.5 °C, 5 ± 0.5% CO2. After pre-incubation of EpiOcular™ tissues and after completion of the treatment with 20 uL PBS, the negative and positive control and the test item was added into the insert atop the concerning EpiOcular triplicate tissues. The plates were placed into the incubator for 30 minutes at 37 ± 1.5 °C, 5 ± 0.5% CO2. After the end of the treatment period the inserts were removed immediately from the cell culture plates. The tissues were rinsed with PBS for 15 times and submerged 3 times in PBS to remove any residual test material. The surface of the skin equivalents was carefully tried using cotton tips as well as by plotting the inserts with blotting paper. The inserts were then placed in 12-well plates supplemented with 5 mL medium per well. After 12 minutes incubation the inserts were transferred to 6-well plates containing 1 mL fresh medium per well. Following, the cell culture plates were placed in the incubator for about 120 minutes. Afterwards the cell viability was determined with the MTT assay.
- RhCE tissue construct used, including batch number: EpiOcular-Kit LotNo.: 19187, KitA
- Doses of test chemical and control substances used: 50 uL (neat test item)
- Duration and temperature of exposure, post-exposure immersion and post-exposure incubation periods (where applicable):
Exposure was for 30 minutes at room temperature.
Post exposure immersion: After the end of the treatment intervals the inserts were removed immediately from the cell culture plates. The tissues were gently rinsed with 15 times with each 1 mL PBS in order to completely remove any residual test material. The surface of the skin equivalents were carefully dried using cotton tips as well as by plotting the inserts with blotting paper. The inserts will then be placed in 12-well plates supplemented with 5 mL medium per well. After 12 ± 0.5 minutes incubation the inserts will be transferred to 6-well plates containing 1 mL fresh medium per well.
Post-exposure incubation: The cell culture plates will be placed in the incubator for 120 ± 15 minutes. Afterwards the cell viability will be determined with the MTT assay.
- Justification for the use of a different negative control than ultrapure H2O (if applicable): Not applicable.
- Justification for the use of a different positive control than neat methyl acetate (if applicable): Not applicable.
- Description of any modifications to the test procedure: Not applicable.
- Indication of controls used for direct MTT-reducers and/or colouring test chemicals (if applicable): Yes. Optical evaluation of the MTT -reducing capacity of the test item after 1 hour incubation with MIT-reagent did not show blue colour. The substance was considered to not directly reduce MTT.
- Number of tissue replicates used per test chemical and controls (positive control, negative control, NSMTT, NSCliving and NSCkilled, if applicable): Triplicate.
- Wavelength and band pass (if applicable) used for quantifying MTT formazan, and linearity range of measuring device (e.g. spectrophotometer): 570 nm microplate reader.
- Description of the method used to quantify MTT formazan
- Description of the qualification of the HPLC/UPLC-spectrophotometry system (if applicable): Not applicable.
- Description of evaluation criteria used including the justification for the selection of the cut-off point for the prediction model: Per SOP (and ECVAM validation).
- Reference to historical positive and negative control results demonstrating suitable run acceptance criteria: Yes (see full study report).
- Complete supporting information for the specific RhCE tissue construct used: Yes (see full study report).
- Reference to historical data of the RhCE tissue construct: Not available.
- Demonstration of proficiency in performing the test method before routine use by testing of the proficiency chemicals: Not available.
- Positive and negative control means and acceptance ranges based on historical data: Yes (per reference literature).
- Acceptable variability between tissue replicates for positive and negative controls: Yes. Standard deviation was < 6.0%.
- Acceptable variability between tissue replicates for the test chemical: Yes. Standard deviation was < 2.0%.
SCORING SYSTEM:
A decrease in number of living cells results in a decrease in the overall activity of mitochondrial dehydrogenases in the sample. This decrease directly correlates to the amount of formazan formed, as monitored by the absorbance. The results for the time-dependant cytotoxicity curves can be presented as the arithmetic mean ± standard deviation. By setting the absorption of the negative control to 100% cell survival the relative absorption calculated for the test item and the positive control can also be described as tissue viability.
Tissue Viability = 100 x (absorption-testitem/positive control –Absorption-blank) / (Absoption-neg.control – Absoption-blank)
Results and discussion
In vitro
Resultsopen allclose all
- Irritation parameter:
- other: TEST ITEM: Mean Relative Absorbance (% of negative control)
- Remarks:
- 30 minutes (exposure)
- Run / experiment:
- mean
- Value:
- 45.8
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other:
- Remarks:
- S.D. 10.5% (n=3)
- Irritation parameter:
- other: POSITIVE CONTROL: Mean Relative Absorbance (% of negative control)
- Remarks:
- 30 minutes (exposure)
- Run / experiment:
- mean
- Value:
- 34.1
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other:
- Remarks:
- S.D. = 0.9 % (n=3)
- Irritation parameter:
- other: NEGATIVE CONTROL: Mean Relative Absorbance (% of negative control)
- Remarks:
- 30 minutes (exposure)
- Run / experiment:
- mean
- Value:
- 100
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other:
- Remarks:
- S.D. = 5% (n=3)
- Other effects / acceptance of results:
- OTHER EFFECTS:
- Visible damage on test system: No.
DEMONSTRATION OF TECHNICAL PROFICIENCY: Concurrent positive control was within the expected range.
ACCEPTANCE OF RESULTS:
- Acceptance criteria met for negative control: Yes. Standard deviation was < 6.0%.
- Acceptance criteria met for positive control: Yes. Standard deviation was < 6.0%.
- Range of historical values if different from the ones specified in the test guideline: Not applicable.
Any other information on results incl. tables
Table 1 Results after treatment
Group |
Mean Absorbance* Tissue 1, 2, 3 Minus Mean Blank |
Mean Absorbance of 3 tissues |
Relative Absorbance (%) Tissue |
SD (%) |
Mean Relative Absorbance (% of negative control) |
Negative control |
1.540 |
1.460 |
102.7 |
5.9 |
100 |
Negative control |
1.559 |
104.0 |
|||
Negative control |
1.401 |
93.2 |
|||
|
|||||
Positive control |
0.546 |
0.498 |
34.6 |
2.2 |
34.1 |
Positive control |
0.501 |
31.6 |
|||
Positive control |
0.501 |
35.9 |
|||
|
|||||
Test item |
0.729 |
0.668 |
47.2 |
1.3 |
45.8 |
Test item |
0.702 |
45.3 |
|||
Test item |
0.692 |
44.7 |
* mean of three replicate wells after blank correction
** relative absorbance (rounded) : 100 x (absorbance-testitem/positivecontrol) / (absorbance-neg.control)
Optical evaluation of the MTT -reducing capacity of the test item after 1 hour incubation with MTT-reagent did not show blue colour. The test item was considered to not directly reduce MTT.
The relative absorbance values of the test item, corresponding to the cell viability, did not decrease below 60% compared with the result of the negative control.
The acceptability criteria) of the assay were met.
The corrected mean OD values of the three tissues exposed to the negative control were>= 1.0 (1.540, 1.559, 1.401)
The mean tissue viability of the positive control is 34.1% of the negative control (<= 60%)
The standard deviation of the three identically treated skin equivalents of each dose group was <= 20% (below 6%)
Applicant's summary and conclusion
- Interpretation of results:
- irritating
- Remarks:
- Criteria used for interpretation of results: expert judgment
- Conclusions:
- Under the conditions of this study the test substance is an eye irritant.
- Executive summary:
The study was performed to assess the irritancy potential of the test item to the eye means of the Human Cornea Model Test using the EpiOcular™ model. The study was performed to GLP. The method was according to manufacturer guideline. Tissues of the human cornea model EpiOcular™ were pre-treated for 30 minutes with PBS. The tissues were exposed to each 50 uL of the test item and of the positive control: methyl acetate (neat) and the negative control (deionised water) for 30 minutes in triplicate. Afterwards the cell viability was determined using the MTT assay. After treatment with the negative control, the mean OD of the three tissues was >= 1.0. Compared with the value of the negative control, treatment with the positive control induced a sufficient decrease in the relative absorbance, and the mean tissue viability was <= 60% of the negative control. The relative standard deviation between each the three identically treated equivalents of each dose group was <= 20%. Consequently, the test met the acceptance criteria. Irritating effects were observed following incubation with test item with a mean tissue viability of 45.8%. The relative absorbance values of the test item, corresponding to the cell viability, decreased below 60% compared with the result of the negative control; consequently, the test item is considered to possess an eye irritating potential.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.